English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/130444
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:

High p27 protein levels in chronic lymphocytic leukemia are associated to low Myc and Skp2 expression, confer resistance to apoptosis and antagonize Myc effects on cell cycle

AuthorsCaraballo, Juan M. ; Acosta, Juan C.; Albajar, Marta ; Gómez-Casares, M. Teresa; Batlle-López, Ana; Cuadrado, M. Ángeles; Bretones, Gabriel ; Llorca, Javier; León, Javier
Chronic lymphocytic leukemia
Issue Date2014
PublisherImpact Journals
CitationOncotarget 5(13): 4694-4708 (2014)
AbstractMyc (c-Myc) counteracts p27 effects, and low p27 usually correlates with high Myc expression in human cancer. However there is no information on the co-expression of both genes in chronic lymphocytic leukemia (CLL). We found a lack of correlation between RNA and protein levels of p27 and Myc in CLL cells, so we determined the protein levels by immunoblot in 107 cases of CLL. We observed a high p27 protein expression in CLL compared to normal B cells. Ectopic p27 expression in a CLL-derived cell line resulted in cell death resistance. Surprisingly, Myc expression was very low or undetectable in most CLL cases analyzed, with a clear correlation between high p27 and low Myc protein levels. This was associated with low Skp2 expression, which is consistent with the Skp2 role in p27 degradation and with SKP2 being a Myc target gene. High Myc expression did not correlate with leukemia progression, despite that cell cycle-related Myc target genes were upregulated. However, biochemical analysis showed that the high p27 levels inhibited cyclin-Cdk complexes even in Myc expressing CLL cells. Our data suggest that the combination of high p27 and low Myc is a marker of CLL cells which is mediated by Skp2.
DescriptionThis is an open-access article distributed under the terms of the Creative Commons Attribution License.-- et al.
Publisher version (URL)http://dx.doi.org/10.18632/oncotarget.2100
Identifiersdoi: 10.18632/oncotarget.2100
e-issn: 1949-2553
Appears in Collections:(IBBTEC) Artículos
Files in This Item:
File Description SizeFormat 
Myc effects.pdf4,96 MBAdobe PDFThumbnail
Show full item record
Review this work

Related articles:

WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.